Triangle Pharmaceuticals (VIRS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Triangle Pharmaceuticals (VIRS)

VIRS 40.03

0.0%

Oct 10 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jack Hartmann who wrote (29)	3/30/2000 12:44:00 PM
From: wbASSETt	Read Replies (1) of 34

NEWS time to rebound ? Triangle names new president, COO DURHAM, N.C., March 27 (Reuters) - Antiviral drug company Triangle Pharmaceuticals Inc. (NASDAQ: VIRS) said Monday it named Chris Rallis president and chief operating officer. Rallis has been with Triangle since 1995 and previously served as executive vice president of business development and general counsel. Rallis replaces Nixon Ellis as president. Ellis resigned in February to pursue other opportunities. Triangle focuses on developing develops antiviral drug therapies for HIV and AIDS. Shares of Triangle closed at 13 on Friday, off a 52-week high of 27-1/4, up from a low of 10-1/4.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next